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Proteinuria in obstructive sleep apnea. ies, adjustment for the presence of confounders was not
Background. Previous studies have reported an association always possible. While 24-hour urine protein measure-
between obstructive sleep apnea (OSA) and proteinuria, but ments were used in most studies, the largest series re-are limited in their ability to assess proteinuria accurately, to
ported to date used urine dipstick to quantitate protein-adjust for confounders such as obesity, or to exclude confidently
uria, and many patients with nephrotic-range proteinuriaunderlying renal disease in patients with OSA and nephrotic-
range proteinuria. did not undergo renal biopsy [2]. Obesity often coexists
Methods. The spot urine protein/creatinine ratio was mea- with OSA and also has been associated with nephrotic-
sured in a prospective consecutive series of 148 patients re-
range proteinuria in multiple case series [7–9] and is pres-ferred for polysomnography who were not diabetic and had not
ent in many of the reported cases of OSA and proteinuriabeen treated previously for OSA. The urine protein/creatinine
ratio was compared across four levels of OSA severity, based [1, 10, 11]. Both obesity and OSA have been associated
on the frequency of apneas and hypopneas per hour: 5 (ab- with similar renal histologic findings, namely, glomerulo-
sent), 5 to 14.9 (mild), 15 to 29.9 (moderate), and30 (severe). megaly and focal segmental sclerosis. Given the uncer-Results. The median level of urine protein/creatinine ratio
tainty regarding the association between proteinuria andin all categories of OSA was 0.2 (range 0.03 to 0.69; median
OSA and the current ability to effectively treat OSA,0.06 in patients with normal apnea hypopnea index, 0.06, 0.07,
0.07 in patients with mild, moderate, and severe OSA, respec- a detailed cross-sectional study in which information was
tively). Eight subjects had a urine protein/creatinine ratio collected in a prospective fashion was conducted to as-
greater than 0.2. Univariate analysis showed a significant asso-
sess the prevalence of nephrotic range proteinuria inciation between urine protein/creatinine ratio and older age
patients who were evaluated for sleep apnea.(P  0.0001), hypertension (P  0.0001), coronary artery dis-
ease (P  0.003), and arousal index (P  0.003). Body mass
index (P  0.16), estimated creatinine clearance (P  0.17),
METHODSand apnea hypopnea index (P  0.13) were not associated
with the urine protein/creatinine ratio. In multiple regression Study design
analysis, only age and hypertension were independent positive
A cross-sectional study was performed that includedpredictors of the urine protein/creatinine ratio (P  0.0001,
R 2  0.17). patients referred to a single sleep laboratory at the De-
Conclusion. Clinically significant proteinuria is uncommon partment of Veterans Affairs Boston Healthcare System
in sleep apnea. Nephrotic range proteinuria should not be
for evaluation of suspected OSA. A consecutive series ofascribed to sleep apnea and deserves a thorough renal evalua-
216 patients was enrolled from July 1999 to March 2000tion.
after obtaining written informed consent. Approval for
the study was obtained from the institutional review
board at the participating institution.Case reports and cross-sectional series have linked
Standard overnight polysomnography was performed,obstructive sleep apnea (OSA) syndrome with the pres-
which included simultaneous recording of electroencepha-ence of nephrotic range proteinuria [1–6]. In these stud-
logram (EEG), electro-oculogram, electromyogram, elec-
trocardiogram, airflow by oronasal thermistry, thoracicKey words: polysomnography, obesity, nephrotic range proteinuria,
hypopnea, urine protein, sleep study. and abdominal excursion by inductance plethysmography,
oxygen saturation, body position, and breathing sounds.
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Hypopnea was defined by a clearly discernible reduction Statistical analysis
in airflow lasting for 10 seconds or longer and associated Descriptive data are presented as means SD for nor-
with either EEG evidence of arousal or a 3% fall in oxy- mally distributed data and as medians for non-normally
hemoglobin saturation [12]. The apnea-hypopnea index distributed data. Assessment of the reproducibility of
(AHI), defined as the frequency of apneas plus hypopneas protein/creatinine ratio measurements was determined
per hour of sleep, was used as a measure of OSA severity. using the intra-class correlation coefficient [16]. Analysis
OSA severity was classified into four categories based of variance (ANOVA) with the generalized linear mod-
on commonly used thresholds of AHI: AHI5 per hour eling approach was used to assess the differences in con-
tinuous variables among categories of OSA. Chi-squaredwas considered normal. An AHI of 5 to 14.9 was indica-
analysis was used to assess differences in proportions oftive of mild OSA. An AHI of 15 to 29.9 was indicative
dichotomous variables among categories of OSA sever-of moderate OSA, and an AHI 30 was indicative of
ity. Univariate associations between urine protein/creati-severe OSA [12]. Arousals were visually scored using the
nine ratio and baseline characteristics were assessed withAmerican Sleep Disorders Association Atlas Task Force
linear regression. Multiple linear regression was useddefinition [13]. The arousal index was defined as the
to assess predictors of proteinuria. Inverse of protein/frequency of arousals per hour of sleep.
creatinine ratio and logarithms of age, creatinine clear-A morning urine sample was analyzed for protein and
ance, and AHI were used in multivariate analysis. Allcreatinine concentrations at a single laboratory. Protein
analyses were performed using NCSS statistical softwarewas measured using the pyrogallol red method and creat-
(NCSS 2000; NCSS.com, Kaysville, UT, USA).inine by the Jaffe rate reaction (Beckman CX9). The pro-
Using a one-way ANOVA and a sample size of 148,tein/creatinine ratio was calculated and used to estimate
the study had 90% power to detect a 0.08 unit (80 mgdaily protein excretion [14]. To determine the variability
protein/24 h) difference in protein/creatinine ratio be-in random urine protein/creatinine ratios, urine samples
tween the severe category and those with AHI of 5 at
were obtained on two separate occasions in 45 subjects.
an  of 0.05.
Patient demographics, medical history, medication pro-
file, and laboratory values were obtained and confirmed
RESULTSby searching each patient’s electronic medical record.
Two definitions of hypertension were used in the study Two hundred sixteen subjects were enrolled in the
for the purpose of multivariate analysis. The first defini- study. Subjects with diabetes (N 49) or previously treated
OSA (N  17) were excluded from the final analysis.tion was the presence of a documented diagnosis of hy-
Two subjects with renal disease and biopsy-proven pri-pertension by a physician. The second was the presence
mary focal segmental glomerulosclerosis (FSGS) alsoof either a documented diagnosis of hypertension by a
were excluded. Each had presented with nephrotic syn-physician or the use of an angiotensin-converting enzyme
drome, renal impairment, and high-grade proteinuria (21(ACE) inhibitor, calcium antagonist, or a  blocker. The
and 18 g/24 h). One had steroid-resistant FSGS, and hislatter definition may have included some patients who
proteinuria did not improve with continuous positive air-were on antihypertensive medications for reasons other
way pressure (CPAP), while the other had steroid-respon-than hypertension such as cardiac disease. The most re-
sive FSGS but relapsed after stopping steroids, in spitecent blood pressure recorded at a clinic visit prior to sleep
of starting CPAP for sleep apnea syndrome. These twostudy was used for systolic and diastolic blood pressure
subjects were found to have moderate and severe OSA.(all patients were seen in a clinic prior to a sleep study).
Baseline characteristics for the 148 study patients areDiabetes was defined as the use of insulin, oral hyogly-
summarized in Table 1. The majority of patients were
cemic agents, or a diagnosis of diabetes controlled by diet.
male (96%). Severity of OSA was associated with increas-
Coronary artery disease was defined as a history of coro- ing age, increasing BMI, and diagnosis of hypertension.
nary artery bypass surgery, myocardial infarction, or an- Minimum oxygen saturation and percentage of sleep time
gina pectoris. Subject’s weight and height were recorded spent below an oxygen saturation of 90% also were asso-
and used to calculate body mass index (BMI; weight in ciated with the severity of OSA, while baseline room air
kg/height in m2). Creatinine clearance was estimated us- oxygen saturation was not.
ing the Cockcroft-Gault formula [15]. Missing serum cre- Protein/creatinine ratios for categories of OSA are pre-
atinine values in 10 subjects with normal blood pressure sented in Figure 1. There was no significant difference in
and normal protein/creatinine ratio were imputed as the urine protein/creatinine ratios among the categories (P
mean for the whole group (1.0). Subjects’ primary care 0.14). The median ratio in each of the four categories
physicians were contacted to confirm the medical profile was less than 0.2, the upper limit of normal, which corre-
in the event that there was no information available in sponds to a 24-hour urine protein excretion of 200 mg
[14]. The greatest ratio observed was 0.69, and therethe electronic medical record.
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Table 1. Characteristics of patients according to category of obstructive sleep apnea (OSA)a
Absent Mild Moderate Severe
(N28) (N37) (N35) (N48) P
Age years 42.6 (29.1–72.1) 53.1 (29.3–80.9) 56.9 (37.2–79.4) 63.1 (30.9–92.6) 0.0001
Body mass index kg/m2 29.3 (19.8–55.7) 28.8 (20.7–40.4) 30.9 (24.4–45) 33.2 (19.8–54.9) 0.002
Serum creatinine mg/dL 0.9 (0.7–1.5) 1.0 (0.8–1.4) 1.0 (0.6–1.5) 1.0 (0.7–1.9) 0.76
Creatinine clearance mL/min 126 (62–271) 106 (49–168) 105 (59–324) 108 (44–285) 0.11
Systolic pressure mm Hg 12416 12715 13216 13417 0.053
Diastolic pressure mm Hg 788 749 7712 7612 0.66
Mean arterial pressure mm Hg 939.3 929.3 9511 9512 0.42
Baseline O2 Satb % 93.42.5 93.72.3 93.42.1 932.5 0.63
Minimum O2 Satc % 89.23.1 86.24.5 84.18.0 83.37.0 0.0006
% O2 Sat 90 d (%) 0 (0–71) 1 (0–86) 4.5 (0–98) 8 (0–99.9) 0.03
Arousal index 19.5 (8–48) 22.5 (9–33) 35 (21–64) 65 (29–119) 0.0001
Sex male 86% 95% 100% 100% 0.01
Hypertensione 25% 27% 46% 67% 0.0003
Hypertension and/or medication usef 36% 39% 49% 73% 0.002
Coronary artery diseaseg 18% 14% 26% 31% 0.23
ACE inhibitor use 11% 8% 29% 31% 0.02
Calcium channel blocker use 18% 16% 11% 27% 0.31
Beta blocker use 18% 19% 29% 46% 0.02
Parametric data are presented as mean  standard deviation. Non-parametric data are presented as median (range). Comparison across categories of OSA
performed with ANOVA for continuous variables and chi-square test for dichotomous variables.
a Defined as absent, apnea hypopnea index (AHI) 5; mild, AHI 5–14.9; moderate, AHI 15–19.9; severe, AHI 30
b Baseline O2 Sat, oxygen saturation on room air taken prior to sleep study
c Minimum O2 Sat, minimum oxygen saturation experienced during sleep study
d % O2 Sat 90, proportion of sleep study time with oxygen saturation less than 90%
e Hypertension, diagnosis of hypertension by a physician
f Hypertension and/or medication use, diagnosis of hypertension by a physician and/or the use of antihypertensive medications
g Includes coronary artery bypass surgery, myocardial infarction or angina pectoris
Table 2. Unadjusted analysis of protein/creatinine ratio with
clinical characteristics
Protein/creatinine ratio P value R 2
Age log 0.0001 0.14
Hypertension 0.0001 0.10
Coronary artery disease 0.003 0.06
Arousal index 0.003 0.06
Use of beta blockers 0.02 0.03
Use of ACE inhibitors 0.05 0.02
Diastolic blood pressure 0.05 0.03
Apnea hypopnea index log 0.13 0.02
Body mass index 0.16 0.01
Creatinine clearance 0.17 0.01
% Time O2 saturation 90% 0.3 0.007
Systolic blood pressure 0.47 0.003
protein/creatinine ratio in diabetics was 1.1 (range 0.02
Fig. 1. Percentile plot of the urine protein/creatinine ratio for catego- to 8.8). Five diabetics had a ratio of greater than 1, and 17
ries of obstructive sleep apnea (OSA). had a ratio of greater than 0.2. There was no association
between OSA and proteinuria in the diabetic subjects.
Results of univariate analysis are presented in Table 2.
Covariates that are significantly related to the protein/were only eight subjects with ratios of greater than 0.2
creatinine ratio include age (P  0.0001), hypertension(5.4%, 95% CI, 1.8 to 9.0%). Three of these observations
(P  0.0001), presence of CAD (P  0.003), and theoccurred in the mild group, and five occurred in the
arousal index (P  0.003). A dichotomous variable wassevere group. Median serum creatinine in these eight
used for hypertension in multivariate analysis because ofsubjects was 1.0 mg/dL, and seven were classified as
its greater predictive value. Multiple regression analysishypertensive by our second definition. Based on paired
using AHI, age, hypertension, and history of coronaryobservations in 45 subjects, the intraclass correlation
artery disease indicates that age (P  0.002) and hyper-coefficient for the reproducibility of protein/creatinine
ratio prior to institution of CPAP was 0.7. The median tension (P  0.048) are independent predictors of pro-
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teinuria (R 2  0.17). Age and hypertension remained reported cases. We reviewed our data in regard to popu-
the only significant predictors in multivariate models re- lation differences with previous reports and also with
gardless of which definition of hypertension was used or regard to the reported association of proteinuria with
if the arousal index was included in the model instead hypertension, obesity, and heart failure. These compari-
of AHI. Neither inclusion of the two patients with FSGS sons offer some explanations for the previously reported
nor exclusion of those using ACE inhibitors altered the reversible proteinuria in OSA. The patients included in
significant predictors in the model. this study differ from those previously described in that
all were stable outpatients and did not have decompen-
sated heart failure or diabetes. Many were treated withDISCUSSION
ACE inhibitors (31%) and  blockers (46%), whichObstructive sleep apnea is a disorder characterized by
might have ameliorated the hemodynamic changes thatrepetitive apneas and hypopneas during sleep. A variety
are a potential cause of proteinuria in OSA patients andof physiologic correlates of OSA have been described,
thus limit the ability to detect an association betweenincluding daytime hypersomnolence, coronary heart dis-
the two entities. In addition, OSA may have been lessease, arrhythmias, pulmonary hypertension, cor pulmo-
severe in this study than in patients previously described,nale, and systemic hypertension [17–22]. Renal conse-
although 17 of the 48 subjects in the severe category hadquences of OSA include nocturnal polyuria and natriuresis,
an AHI60 in this study. Previously reported series didboth of which are prevented with nasal CPAP therapy
not adequately exclude underlying primary renal disease[23]. Enuresis has also been described in children with
in patients with nephrotic-range proteinuria. They alsoOSA [24]. Limited data have suggested that OSA is associ-
did not control for the potential confounding effects ofated with proteinuric renal disease. Chaudhary et al re-
hypertension or obesity [2].ported nephrotic range proteinuria in 3 of 34 patients
There is increasing evidence that OSA is an indepen-with OSA and 3 proteinuria by dipstick in a further 3
patients [5]. A three-year follow-up on four of the pa- dent predictor of prevalent hypertension even after ad-
tients who underwent tracheostomy showed that protein- justment for age, sex, body habitus, and other known
uria was undetectable in three of the patients and less hypertension risk factors [20, 21, 25–29]. Hypertension
than 500 mg per day in the fourth. A subsequent article has been associated with microalbuminuria and might
compared the degree of proteinuria in obese patients be a confounder of the association of OSA with protein-
with (N  14) and without sleep apnea (N  12) to nine uria or a mechanism underlying a causal association be-
healthy volunteers with normal sleep studies [4]. Noctur- tween the two [30–32]. While we confirm an association
nal protein excretion rate in the obese patients with OSA between hypertension and proteinuria in this study, we
was significantly greater than that in the obese group find no evidence that OSA is an independent cause of
without OSA (P  0.05), although the greatest degree proteinuria. Moreover, as hypertension has not been as-
of proteinuria observed was 475 	g/min (1 g/24 h). In sociated with reversible nephrotic range proteinuria in
1995, the same group determined the level of proteinuria patients with normal renal function, it is unlikely that
by dipstick in a consecutive series of 407 patients with hypertension was an important etiologic factor in prior
OSA. There were 9 patients with 4 and 10 patients case reports of nephrotic range proteinuria in OSA pa-
with 3 proteinuria. AHI was greater in subjects with tients [6, 33, 34].
4 proteinuria compared with all of the other categories
Obesity is extremely common in patients with OSA,
(P  0.05) [2].
and greater weight has been clearly associated with moreIn contrast, we have found that increased protein excre-
severe OSA in many series, including this one [35]. Simi-tion is uncommon in clinically stable outpatients across
lar degrees of proteinuria as well as similar pathologicalall categories of OSA severity. Nephrotic range protein-
findings have been described in patients with obesity anduria did not occur in any of the 148 patients evaluated.
those with OSA. Various histologic patterns have beenMedian levels of protein excretion as assessed by the
described, including normal appearance [11], glomerulo-urine protein/creatinine ratio were within normal limits
megaly [1, 3], FSGS [1, 3, 9, 10, 36], mesangial prolifera-across all categories of OSA, and the greatest level of
tive changes [36], and minimal change pattern [5, 36].protein excretion observed in this population was less
Kasiske and Crosson reported that of 17 obese nephroticthan 1 g per day. These results indicate that clinically
patients, 9 had FSGS, 2 had minimal change disease andsignificant proteinuria is uncommon in this population.
fibrosis, and 5 had diabetic nephropathy, whereas age-Despite the low levels of proteinuria observed, systemic
and sex-matched nonobese nephrotic controls had mem-hypertension and increasing age were independent pre-
branous nephropathy in almost half of the cases [7]. Moredictors of the degree of proteinuria.
recent prospective studies have documented microalbu-There are a number of possible explanations for the
disparity between the results of our study and previously minuria (30 to 300 mg albumin per 24-hour period) in
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10 to 14% of obese subjects [37–39]. Similarly, studies gestive heart failure [46], and it is possible that glomeru-
lar hemodynamic changes that occur as a consequencein large cohorts have demonstrated a significant relation-
of neurohormonal activation in congestive heart failureship between microalbuminuria and high BMI [40].
and obesity may explain the reversible nature of theObesity is strongly associated with both hypertension
proteinuria that has been reported in both of these condi-and diabetes mellitus, and in a cross-sectional study of
tions. Both animal and human studies indicate that over-5174 Japanese male workers, the proportion of subjects
activity of the sympathetic nervous system is related towith 1 proteinuria or greater as assessed by reagent
sustained hypertension in OSA [47, 48].strip was greater in obese subjects only if they had hyper-
There are a number of limitations to the current study.tension or elevated HbA1c 5.9% [41]. A relationship
The referral nature of the study population and the cross-between BMI and proteinuria was not seen in our study,
sectional nature of the study design would limit our abil-possibly because the urine protein to creatinine ratio
ity to draw any conclusion about the causal relationshipmeasures total protein rather than albumin and may be
between OSA and proteinuria had one been identified;an insensitive marker for proteinuria in the microalbumi-
however, there is no reason to expect that either of thesenuric range. In addition, our sample included few non-
factors would bias the study toward the observed nullobese subjects (as is typical of a population referred for
result. The observation of two nondiabetic patients withsuspected OSA), and many subjects were using ACE
nephrotic range proteinuria in this study is not unex-inhibitors, two factors that might impair our ability to
pected given the referral nature of the population, asassess this association.
the presence of proteinuria may have influenced the deci-While obesity appears to be associated with micro-
sion to refer for evaluation of sleep apnea. While thealbuminuria in population studies, there are several case
evidence for a lack of association between OSA and pro-reports of nephrotic-range proteinuria that resolved with
teinuria may be limited by exclusion of these two pa-weight loss in obese patients, many of whom may have
tients, their exclusion is appropriate based on the findingshad OSA. A number of authors have reported a reduc-
of primary FSGS on biopsy, massive proteinuria on pre-tion in the level of proteinuria with weight loss in obese
sentation, and response to therapy, which imply that thissubjects [9–11]. Sklar and Chaudhary reported the rever-
was a primary renal process and not secondary FSGSsal of subnephrotic-range proteinuria in two patients
previously reported in association with OSA. Moreover,with evidence of obesity, chronic hypoventilation, right
inclusion of these patients did not alter the overall nega-heart failure (often called the Pickwickian syndrome),
tive findings of this study. Although it is unlikely thatand OSA treated with tracheostomy [6]. In one of the
the physiology of OSA differs by gender, since the popu-cases, remission of proteinuria preceded tracheostomy
lation studied was overwhelmingly male, the results ofand coincided with a dramatic improvement in blood
this analysis are generalizable only to males. Prospectiveoxygen levels and a diuresis of 50 pounds in three weeks.
cohort studies evaluating changes in proteinuria withThe association in several reports of improvement in
time would provide more information on the causal rela-proteinuria with reductions in central venous pressure
tionship between OSA and proteinuria if such a relation-or with captopril suggests that hemodynamic factors may
ship exists.be important in causing nephrotic range proteinuria in
The results of the current study indicate that nephroticthese cases [6, 36]. In addition, the fact that levels of
range-proteinuria is uncommon in hemodynamically sta-proteinuria following intervention were still elevated
ble male outpatients with OSA. The cause of nephrotic-may represent selection of obese patients with subtle
range proteinuria previously reported in patients with OSAunderlying glomerular disease that is exacerbated by
is not known, although decompensated heart failure mayobesity-induced hemodynamic alterations.
have been an etiologic factor. From a management per-It is well recognized that severe OSA can lead to pul-
spective, patients with OSA and moderate-to-severe pro-monary hypertension and right-sided heart failure. Tran-
teinuria in the absence of decompensated heart failuresient proteinuria has been reported in hospitalized pa-
should undergo a thorough renal evaluation to excludetients with congestive heart failure, which is in the range
potentially treatable kidney disease.reported previously in cases of OSA [42, 43]. While the
relationship of cardiac disease to urinary albumin ex-
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